Article Figures & Data
Figures
- FIG. 1.
IgG ACEA titers in healthy controls, patients with IBD, and patients with intestinal Behçet's disease. IgG ACEA titers were significantly higher in patients with IBD than in controls. Error bars indicate standard deviations.
- FIG. 2.
IgG ACEA and 5-aminosalicylate derivatives. Patients with CD taking sulfasalazine or mesalazine had significantly lower IgG ACEA titers than patients with CD not taking these drugs. n.s., not significant. Error bars indicate standard deviations.
- FIG. 3.
IgG subclass ACEA titers in healthy controls, patients with IBD, and patients with intestinal Behçet's disease. IgG2 ACEA titers were significantly higher in patients with IBD and intestinal Behçet's disease than in controls. IgG3 ACEA titers were significantly higher in patients with CD than in patients with UC. Error bars indicate standard deviations.
- FIG. 4.
IgG subclass ACEA titers and disease involvement in patients with IBD. IgG3 ACEA titers were significantly higher for CD colitis than for total and left-sided UC and were significantly higher for CD ileitis than for left-sided UC. Error bars indicate standard deviations.
- FIG. 5.
IgG subclass ACEA titers and 5-aminosalicylate derivatives. IgG2 ACEA titers were significantly lower in patients with CD taking either sulfasalazine or mesalazine than in patients not taking these drugs. Error bars indicate standard deviations.
Tables
- TABLE 1.
Clinical features of patients with UC and CD
Characteristic Value for group UC CD No. of patients 29 30 Male/female 12/17 15/15 Mean age; range (yr) 35; 20-55 31; 18-67 Active/quiescent 10/19 15/15 Disease location Small bowel 6 Large bowel 10 Small and large bowel 14 Left-sided colitis 29 Total colitis 9 Medical treatment Sulfasalazine or mesalazine 23 19 Corticosteroids 9 8 Dietary therapy 0 16
